European Journal of Biomedical and Pharmaceutical Sciences

INFORMATION TECHNIQUE IN BIOSYSTEM BY CHEMINFORMATICS & BIOINFORMATICS: A UNIQUE TOOL IN DRUG DISCOVERY

Dhrubo Jyoti Sen*

ABSTRACT

Chemoinformatics involves integrating the principles of physical chemistry with computer-based and information science methodologies, commonly referred to as ―in silico techniques‖, in order to address a wide range of descriptive and prescriptive chemistry issues, including applications to biology, drug discovery, and related molecular areas. On the other hand, the incorporation of machine learning has been considered of high importance in the field of drug design, enabling the extraction of chemical data from enormous compound databases to develop drugs endowed with significant biological features. The present review discusses the field of cheminformatics and proposes the use of virtual chemical libraries in virtual screening methods to increase the probability of discovering novel hit chemicals. The virtual libraries address the need to increase the quality of the compounds as well as discover promising ones. On the other hand, various applications of bioinformatics in disease classification, diagnosis, and identification of multidrug-resistant organisms were discussed. The use of ensemble models and brute-force feature selection methodology has resulted in high accuracy rates for heart disease and COVID-19 diagnosis, along with the role of special formulations for targeting meningitis and Alzheimer‘s disease. Additionally, the correlation between genomic variations and disease states such as obesity and chronic progressive external ophthalmoplegia, the investigation of the antibacterial activity of pyrazole and benzimidazole-based compounds against resistant microorganisms, and its applications in chemoinformatics for the prediction of drug properties and toxicity—all the previously mentioned—were presented in the current review. The sensible use of bioinformatics and chemoinformatics in drug research and discovery holds significant potential for the introduction of novel and more potent pharmaceuticals. This covers how genetic variants affect medication response, which includes enhancing the qualities of currently available drugs as well as the health of people, animals, and plant communities. In order to identify novel compounds, design molecules for selectivity, efficacy, and safety, and generate clinical trial candidates from novel compounds, this also makes use of a broad range of computational scientific approaches. Over the past few years, there has been an increase in the creation of new, accurate computational methods for drug design due to the synergistic interaction between medical chemistry and bioinformatics. The primary objective is the drug, where binding mode, interaction, binding site, and binding energy are estimated using computer-based techniques such molecular docking, de novo design, and other virtual screening methods. Consequently, I will assess the linked product based on contemporary informatics, the sophisticated approach for rational drug design, and the relationship between the drug development process and safety in this study. In drug discovery, bioinformatics enables the efficient analysis and interpretation of large scale biological data, facilitating target identification, lead compound optimization and prediction of drug target interactions.

Keywords: Chemoinformatics; Bioinformatics; Applications; Formulation; Advances.